Table 1.
Health facility and health worker readiness to implement ‘test and treat’ policy
| Health facilities (N = 41) | n | % |
|---|---|---|
| Malaria diagnostic services | ||
| Routinely providing malaria microscopy service | 26 | 63.4 |
| Malaria microscopy service functional on survey days | 20 | 48.8 |
| Malaria RDTs in stock | 40 | 97.6 |
| Any functional diagnostics on survey days (microscopy or RDTs) | 41 | 100 |
| Anti-malarial medicines (non-expired) | ||
| Artemether-lumefantrine (at least one pack in stock) | 39 | 95.1 |
| Artemether-lumefantrine (all 4 packs in stock) | 31 | 75.6 |
| Artesunate suppositories | 30 | 73.2 |
| Artesunate injections | 27 | 65.8 |
| Primaquine tablets | 26 | 63.4 |
| Chloroquine tablets | 40 | 97.6 |
| Quinine tablets | 26 | 63.4 |
| Quinine injections | 20 | 48.8 |
| Health workers (N = 67) | n | % |
|---|---|---|
| Exposure to in-service training | ||
| Trained how to perform RDTs | 47 | 70.2 |
| Ever trained on malaria case management | 40 | 59.7 |
| Trained on malaria case management since 2009a | 36 | 53.7 |
| Trained on malaria case management since 2012a | 21 | 31.3 |
| Exposure to job aids | ||
| Malaria treatment guideline | 46 | 68.7 |
| RDT use job aid | 47 | 70.2 |
| Exposure to supportive supervision in past 6 months | ||
| Any supervisory visit | 49 | 73.1 |
| Malaria supervisory visit | 45 | 67.2 |
aAll training since 2009 recommended AL and artesunate treatment while only training from 2012 recommended testing of all patients with fever and anti-malarial treatment of only test-positive results. Training prior to 2012 did not provide testing criteria and was ambiguous about interpretation of test-negative results